Search | VHL Search Portal

1.

The Myriad Decision at 10.

Sherkow, Jacob S; Cook-Deegan, Robert; Greely, Henry T.

Annu Rev Genomics Hum Genet ; 2024 Feb 29.

Article in English | MEDLINE | ID: mdl-38424474

2.

Ethical, legal, and social issues in the Earth BioGenome Project.

Sherkow, Jacob S; Barker, Katharine B; Braverman, Irus; Cook-Deegan, Robert; Durbin, Richard; Easter, Carla L; Goldstein, Melissa M; Hudson, Maui; Kress, W John; Lewin, Harris A; Mathews, Debra J H; McCarthy, Catherine; McCartney, Ann M; da Silva, Manuela; Torrance, Andrew W; Greely, Henry T.

Proc Natl Acad Sci U S A ; 119(4)2022 01 25.

Article in English | MEDLINE | ID: mdl-35042809

3.

Preprint servers and patent prior art: Preprints can jeopardize the patentability of an invention: Preprints can jeopardize the patentability of an invention.

Sherkow, Jacob S.

EMBO Rep ; 23(2): e54439, 2022 02 03.

Article in English | MEDLINE | ID: mdl-34914166

4.

Models of Technology Transfer for Genome-Editing Technologies.

Graff, Gregory D; Sherkow, Jacob S.

Annu Rev Genomics Hum Genet ; 21: 509-534, 2020 08 31.

Article in English | MEDLINE | ID: mdl-32151165

5.

The History of Patenting Genetic Material.

Sherkow, Jacob S; Greely, Henry T.

Annu Rev Genet ; 49: 161-82, 2015.

Article in English | MEDLINE | ID: mdl-26442843

6.

FAMILIAL SEARCHES, THE FOURTH AMENDMENT, AND GENOMIC CONTROL.

Sherkow, Jacob S; Ram, Natalie; Gunter, Carl A.

South Calif Law Rev ; 96(PS1): 1-14, 2022.

Article in English | MEDLINE | ID: mdl-37928339

7.

Fortune and hindsight: gene patents' muted effect on medical practice.

Sherkow, Jacob S; Abbott, Ryan.

Br Med Bull ; 126(1): 37-45, 2018 06 01.

Article in English | MEDLINE | ID: mdl-29608656

8.

Regulating Direct-to-Consumer Polygenic Risk Scores.

Sherkow, Jacob S; Park, Jin K; Lu, Christine Y.

JAMA ; 330(8): 691-692, 2023 08 22.

Article in English | MEDLINE | ID: mdl-37535347

9.

Assessing-and Extending-California's Insulin Manufacturing Initiative.

Sherkow, Jacob S; Adashi, Eli Y; Cohen, I Glenn.

JAMA ; 329(7): 533-534, 2023 02 21.

Article in English | MEDLINE | ID: mdl-36656599

10.

CRISPR: Pursuit of profit poisons collaboration.

Sherkow, Jacob S.

Nature ; 532(7598): 172-3, 2016 Apr 14.

Article in English | MEDLINE | ID: mdl-27075081

11.

CRISPR, Patents, and the Public Health.

Sherkow, Jacob S.

Yale J Biol Med ; 90(4): 667-672, 2017 12.

Article in English | MEDLINE | ID: mdl-29259531

12.

Patent Law's Reproducibility Paradox.

Sherkow, Jacob S.

Duke Law J ; 66(4): 845-911, 2017 Jan.

Article in English | MEDLINE | ID: mdl-28117563

13.

Governing Human Germline Editing Through Patent Law.

Sherkow, Jacob S; Adashi, Eli Y; Cohen, I Glenn.

JAMA ; 326(12): 1149-1150, 2021 Sep 28.

Article in English | MEDLINE | ID: mdl-34459849

14.

Patent Eligibility Reform and the Public Health.

Sherkow, Jacob S.

Milbank Q ; 97(3): 654-658, 2019 09.

Article in English | MEDLINE | ID: mdl-31321802

15.

Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.

Sherkow, Jacob S.

EMBO Rep ; 18(7): 1047-1051, 2017 07.

Article in English | MEDLINE | ID: mdl-28536246

16.

Immaculate Conception? Priority and Invention in the CRISPR Patent Dispute.

Sherkow, Jacob S.

CRISPR J ; 5(2): 174-180, 2022 04.

Article in English | MEDLINE | ID: mdl-35438517

17.

Handle with Care: The WHO Report on Human Genome Editing.

Cohen, I Glenn; Sherkow, Jacob S; Adashi, Eli Y.

Hastings Cent Rep ; 52(2): 10-14, 2022 03.

Article in English | MEDLINE | ID: mdl-35476355

18.

Governance Choices of Genome Editing Patents.

Scheinerman, Naomi; Sherkow, Jacob S.

Front Polit Sci ; 32021.

Article in English | MEDLINE | ID: mdl-35557745

19.

Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.

Trück, Johannes; Eugster, Anne; Barennes, Pierre; Tipton, Christopher M; Luning Prak, Eline T; Bagnara, Davide; Soto, Cinque; Sherkow, Jacob S; Payne, Aimee S; Lefranc, Marie-Paule; Farmer, Andrew; Bostick, Magnolia; Mariotti-Ferrandiz, Encarnita.

Elife ; 102021 05 26.

Article in English | MEDLINE | ID: mdl-34037521

20.

Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.

Angrist, Misha; Barrangou, Rodolphe; Baylis, Françoise; Brokowski, Carolyn; Burgio, Gaetan; Caplan, Arthur; Chapman, Carolyn Riley; Church, George M; Cook-Deegan, Robert; Cwik, Bryan; Doudna, Jennifer A; Evans, John H; Greely, Henry T; Hercher, Laura; Hurlbut, J Benjamin; Hynes, Richard O; Ishii, Tetsuya; Kiani, Samira; Lee, LaTasha Hoskins; Levrier, Guillaume; Liu, David R; Lunshof, Jeantine E; Macintosh, Kerry Lynn; Mathews, Debra J H; Meslin, Eric M; Mills, Peter H R; Montoliu, Lluis; Musunuru, Kiran; Nicol, Dianne; O'Neill, Helen; Qiu, Renzong; Ranisch, Robert; Sherkow, Jacob S; Soni, Sheetal; Terry, Sharon; Topol, Eric; Williamson, Robert; Zhang, Feng; Davies, Kevin.

CRISPR J ; 3(5): 332-349, 2020 10.

Article in English | MEDLINE | ID: mdl-33095048

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

The Myriad Decision at 10.

Ethical, legal, and social issues in the Earth BioGenome Project.

Preprint servers and patent prior art: Preprints can jeopardize the patentability of an invention: Preprints can jeopardize the patentability of an invention.

Models of Technology Transfer for Genome-Editing Technologies.

The History of Patenting Genetic Material.

FAMILIAL SEARCHES, THE FOURTH AMENDMENT, AND GENOMIC CONTROL.

Fortune and hindsight: gene patents' muted effect on medical practice.

Regulating Direct-to-Consumer Polygenic Risk Scores.

Assessing-and Extending-California's Insulin Manufacturing Initiative.

CRISPR: Pursuit of profit poisons collaboration.

CRISPR, Patents, and the Public Health.

Patent Law's Reproducibility Paradox.

Governing Human Germline Editing Through Patent Law.

Patent Eligibility Reform and the Public Health.

Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.

Immaculate Conception? Priority and Invention in the CRISPR Patent Dispute.

Handle with Care: The WHO Report on Human Genome Editing.

Governance Choices of Genome Editing Patents.

Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.

Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.